Suchergebnisse - "Nnabuife, Christina"

PubPharm (6)

1

Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors

enthalten in: bioRxiv.org | 2024

von Moghadasi, S. | Heilmann, E. | Khalil, A. | +12

2

The mechanism of ceftazidime and cefiderocol hydrolysis by D179Y variants of KPC carbapenemases is similar and involves the formation of a long-lived covalent intermediate

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Birgy, A. | Nnabuife, C. | Palzkill, T.

3

Copy number flexibility facilitates heteroresistance to increasing antibiotic pressure and threatens the beta-lactam pipeline

enthalten in: bioRxiv.org | 2024

von Choby, J. | Ozturk, T. | Abbott, C. | +6

4

DNA-encoded chemical libraries yield non-covalent and non-peptidic SARS-CoV-2 main protease inhibitors

enthalten in: Communications chemistry | 2023

von Jimmidi, R. | Chamakuri, S. | Lu, S. | +21

5

Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors

enthalten in: Science advances | 2023

von Moghadasi, S. | Heilmann, E. | Khalil, A. | +12

UpdateOf: bioRxiv. 2022 Dec 26;:. - PMID 35982678

6

Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors

enthalten in: bioRxiv : the preprint server for biology | 2022

von Moghadasi, S. | Heilmann, E. | Khalil, A. | +12

UpdateIn: Sci Adv. 2023 Mar 29;9(13):eade8778. - PMID 36989354

1
[1]